{"title": "Potencial Adyuvante para la Vacuna contra la COVID-19 del Suplemento Diet\u00e9tico Nichi Glucan del Jap\u00f3n", "author": null, "url": "https://www.businesswire.com/news/home/20210303005703/es/", "hostname": "businesswire.com", "description": "Se ha recomendado que los \u00df-glucanos producidos por la cepa AFO-202 de la levadura negra Aureobasidium Pullulans (Nichi Glucan), que tienen el potenci", "sitename": "Businesswire", "date": "2021-03-03", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "TOKIO--(\n[BUSINESS WIRE](https://www.businesswire.com/))--Se ha recomendado que los \u00df-glucanos producidos por la cepa AFO-202 de la levadura negra Aureobasidium Pullulans (Nichi Glucan), que tienen el potencial para mejorar el sistema inmunitario a trav\u00e9s de todas las v\u00edas principales, son valiosos para estudios cl\u00ednicos para su validaci\u00f3n como adyuvante de la vacuna contra la COVID-19 ( [https://doi.org/10.1080/21645515.2021.1880210](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1080%2F21645515.2021.1880210&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1080%2F21645515.2021.1880210&index=1&md5=87a3c4f575995184311047037d0654be)). Los pat\u00f3genos que entran por la v\u00eda nasal u oral se ven atacados por la inmunidad de la mucosa y los anticuerpos en la saliva y, una vez dentro del cuerpo, por el sistema inmunitario innato y adaptativo y la inmunidad entrenada (Trained Immunity, TRIM). Seg\u00fan describe la revista de art\u00edculos cient\u00edficos asociada con la International Society of Vaccines, el Nichi Glucan puede producir efectos beneficiosos a trav\u00e9s de todo lo mencionando anteriormente.\nEl Nichi Glucan como adyuvante de la vacuna: Los adyuvantes son agentes que complementan las vacunas al potenciarlas o estabilizarlas. El Nichi Glucan con potencial inmunomodulador se considera m\u00e1s ventajoso, ya que se ha informado su eficacia adyuvante de la vacuna contra la gripe aviar (H5N1, H5N2) (\n[https://pubmed.ncbi.nlm.nih.gov/21532325/](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F21532325%2F&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F21532325%2F&index=2&md5=4b990c4e5f0f463ff347e821287e2abf)), tiene una trayectoria de seguridad de consumo como suplemento alimenticio en el Jap\u00f3n desde 1996 y los efectos beneficiosos para la salud en general se documentan en los estudios en personas que se describen a continuaci\u00f3n.\n-\nMejora inmunitaria y beneficios de equilibrio en estudios en pacientes con c\u00e1ncer y voluntarios saludables de la tercera edad y j\u00f3venes adultos (\n[https://doi.org/10.3389/fimmu.2020.01548](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.3389%2Ffimmu.2020.01548&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.3389%2Ffimmu.2020.01548&index=3&md5=4532e17b722eca97ffc07c6c8f4b8486))\n-\nLa coagulopatia relacionada con la COVID-19 podr\u00eda abordarse en grupos de personas con alto riesgo de trastornos de coagulaci\u00f3n sangu\u00ednea; Thrombosis (\n[https://doi.org/10.1186/s12959-020-00239-6](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1186%2Fs12959-020-00239-6&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1186%2Fs12959-020-00239-6&index=4&md5=e024fc268e835430e0425fc5ed40e893))\n-\nEl potencial del equilibrio entre la glucosa en sangre y el colesterol podr\u00eda reducir la mortalidad en pacientes con SARS-CoV-2; Journal of Diabetes & Metabolic Disorders (\n[https://doi.org/10.1007/s40200-020-00664-4](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1007%2Fs40200-020-00664-4&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1007%2Fs40200-020-00664-4&index=5&md5=5ffbef2791ed96bbe587468a272e8984)).\n- Se ha informado que los betaglucanos en la inmunidad entrenada son m\u00e1s s\u00f3lidos, ya que act\u00faan sobre la m\u00e9dula \u00f3sea, que produce componentes sangu\u00edneos y c\u00e9lulas inmunitarias.\nAnteriormente, a los asociados de GN Corporation se les otorg\u00f3 una patente sobre anticuerpos neutralizantes de la gripe para identificar al grupo de personas vulnerable para la administraci\u00f3n de vacunas, realizado en colaboraci\u00f3n con el Dr. Yoshikazu Kurosawa, investigador de anticuerpos monoclonales, reconocido por el Prof. Susumu Tonegawa en su conferencia en 1987 tras recibir el premio Nobel de Medicina (\n[https://www.nobelprize.org/uploads/2018/06/tonegawa-lecture.pdf](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F06%2Ftonegawa-lecture.pdf&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F06%2Ftonegawa-lecture.pdf&index=6&md5=6a4594bc31df3c0056d254e25b220bda)).\nLos seres humanos carecen de la capacidad de mutar ventajosamente su ADN o ARN a diferencia de los virus; por lo tanto, solo cuentan con la \u00fanica opci\u00f3n de estimular su sistema inmunitario para protegerse de la evoluci\u00f3n de nuevos pat\u00f3genos y de virus mutantes. Los hongos han contribuido significativamente a la salud humana al producir agentes antimicrobianos como la penicilina y muchos agentes anticancer\u00edgenos, por lo que una investigaci\u00f3n m\u00e1s precisa sobre esta levadura negra parece muy prometedora, expres\u00f3 el Dr. Gene Kurosawa, coautor del estudio. Se est\u00e1n realizando estudios cl\u00ednicos sobre los potenciales prebi\u00f3ticos del Nichi Glucan para tratar la disbiosis intestinal mediante el equilibrio de la microbiota intestinal.\nEl texto original en el idioma fuente de este comunicado es la versi\u00f3n oficial autorizada. Las traducciones solo se suministran como adaptaci\u00f3n y deben cotejarse con el texto en el idioma fuente, que es la \u00fanica versi\u00f3n del texto que tendr\u00e1 un efecto legal.", "language": null, "image": "https://mms.businesswire.com/media/20210303005703/es/862870/23/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_viewimage.jpg", "pagetype": "article", "links": ["http://www.businesswire.com/", "https://mms.businesswire.com/media/20210303005703/es/862870/5/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_highres.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/4/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_webready.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/3/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_viewimage.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/2/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_thumbnail.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/5/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_highres.jpg?download=1", "https://www.businesswire.com/news/home/20210303005703/es/4931354/", "https://mms.businesswire.com/media/20210303005703/es/862870/5/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_highres.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/4/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_webready.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/3/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_viewimage.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862870/2/Nichi_Glucan_Vaccine-Adj_ill_for_PR_OL_final_03mar21_thumbnail.jpg?download=1", "https://www.businesswire.com/news/home/20210303005703/es/4931355/", "https://mms.businesswire.com/media/20210303005703/es/862869/5/Nich_Glucan_Logo02_PR01_highres.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862869/4/Nich_Glucan_Logo02_PR01_webready.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862869/3/Nich_Glucan_Logo02_PR01_viewimage.jpg?download=1", "https://mms.businesswire.com/media/20210303005703/es/862869/2/Nich_Glucan_Logo02_PR01_thumbnail.jpg?download=1", "https://www.businesswire.com/", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1080%2F21645515.2021.1880210&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1080%2F21645515.2021.1880210&index=1&md5=87a3c4f575995184311047037d0654be", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F21532325%2F&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F21532325%2F&index=2&md5=4b990c4e5f0f463ff347e821287e2abf", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.3389%2Ffimmu.2020.01548&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.3389%2Ffimmu.2020.01548&index=3&md5=4532e17b722eca97ffc07c6c8f4b8486", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1186%2Fs12959-020-00239-6&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1186%2Fs12959-020-00239-6&index=4&md5=e024fc268e835430e0425fc5ed40e893", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fdoi.org%2F10.1007%2Fs40200-020-00664-4&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fdoi.org%2F10.1007%2Fs40200-020-00664-4&index=5&md5=5ffbef2791ed96bbe587468a272e8984", "https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F06%2Ftonegawa-lecture.pdf&esheet=52389770&newsitemid=20210303005703&lan=es-AR&anchor=https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F06%2Ftonegawa-lecture.pdf&index=6&md5=6a4594bc31df3c0056d254e25b220bda", "mailto:info@gncorporation.com", "https://www.nichiglucan.com", "mailto:info@gncorporation.com", "/portal/site/home/my-business-wire/", "/portal/site/home/welcome/", "https://membership.businesswire.com/choose-country", "https://services.businesswire.com/", "/portal/site/home/news/", "/portal/site/home/news/", "/portal/site/home/news/multimedia/", "/portal/site/home/news/industries/", "/portal/site/home/news/subjects/", "/portal/site/home/news/languages/", "https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31356", "https://services.businesswire.com/resources-education", "https://services.businesswire.com/resources-education", "https://blog.businesswire.com/", "https://services.businesswire.com/distribution-analytics/distribution-lists", "https://services.businesswire.com/media-journalist-tools", "https://services.businesswire.com/resources-education/sample-press-release", "https://services.businesswire.com/find-your-news-online", "https://services.businesswire.com/resources-education/disclosure-resources", "https://services.businesswire.com/about-us", "https://services.businesswire.com/about-us", "https://membership.businesswire.com/sign-up", "https://services.businesswire.com/contact-us", "https://services.businesswire.com/careers", "https://newsroom.businesswire.com", "https://newsroom.businesswire.com/events", "/portal/site/home/search?javax.portlet.tpst=503a8767054f0df6a9e77a100d908a0c&javax.portlet.pbp_503a8767054f0df6a9e77a100d908a0c_view=advancedSearch&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken", "/portal/site/home/template.LOGIN/", "/portal/site/home/signup/", "http://twitter.com/businesswire/", "http://www.linkedin.com/companies/business-wire", "http://www.businesswire.com/blog", "http://www.businesswire.co.uk/", "http://www.businesswire.de/", "http://www.businesswire.fr/", "http://www.businesswire.hk/", "http://www.businesswire.it/", "http://www.businesswire.jp/", "http://www.tradeshownews.com/", "http://newsroom.businesswire.com/contact", "https://services.businesswire.com/uk-tax-strategy-page", "https://services.businesswire.com/privacy", "#", "/portal/site/home/terms-of-use/", "/portal/site/home/copyright/", "https://www.google.com/chrome/", "https://www.microsoft.com/edge", "https://www.mozilla.org/firefox/", "https://support.apple.com/downloads/safari", "https://www.google.com/chrome/", "https://www.microsoft.com/edge", "https://www.mozilla.org/firefox/", "https://support.apple.com/downloads/safari"]}